Albireo Pharma, Inc, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders.

Source: https://www.americanbankingnews.com/2023/01/11/albireo-pharma-nasdaqalbo-downgraded-by-cowen.html

BioXcel Therapeutics, Inc is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology.

Source: https://www.americanbankingnews.com/2023/01/03/artemis-investment-management-llp-cuts-stake-in-bioxcel-therapeutics-inc-nasdaqbtai.html

I estimate that the burn rate will be about $25 million per year based solely on my exposure to other early commercial-stage medical device companies.

Source: https://seekingalpha.com/article/4617330-renalytix-commercialising-first-ai-kidney-disease-diagnostic-tool?source=feed_all_articles

Paratek Pharmaceuticals, Inc, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use.

Source: https://www.etfdailynews.com/2023/08/10/hc-wainwright-reaffirms-neutral-rating-for-paratek-pharmaceuticals-nasdaqprtk/

Paratek Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel therapies for life-threatening diseases and other public health threats.

Source: https://forextv.com/top-news/leading-independent-proxy-advisory-firm-iss-recommends-paratek-pharmaceuticals-stockholders-vote-for-the-acquisition-by-gurnet-point-capital-and-novo-holdings/